Rationale: The diagnostic usefulness and safety of transbronchial lung cryobiopsy for the
evaluation of interstitial lung disease remain unclear. Objectives: This systematic review and …

Background Progressive fibrosing interstitial lung disease (PF-ILD) is characterised by
progressive physiological, symptomatic and/or radiographic worsening. The real-world …

Importance Particulate matter 2.5 μm or less in diameter (PM 2.5 ) is associated with adverse
outcomes in idiopathic pulmonary fibrosis, but its association with other fibrotic interstitial …

… Wong MD a b , Lee Fidler MD c , Veronica Marcoux MD d , Kerri A. Johannson MD e ,
Deborah Assayag MD f , Jolene H. Fisher MD g , Nathan Hambly MD h , Martin Kolb MD h , Julie …

Rationale: Fibrotic interstitial lung disease (fILD) is a group of pathologic entities characterized
by scarring of the lungs and high morbidity and mortality. Research investigating how …

Background Comorbidities are frequent and have been associated with poor quality of life,
increased hospitalizations, and mortality in patients with interstitial lung disease (ILD). …

Background and objective Inhalational exposures are a known cause of interstitial lung
disease (ILD), but little is understood about their prevalence across ILD subtypes and their …

Methods Patients with IPF (1) with access to a smartphone/tablet and residential wireless
Internet were prospectively enrolled. Patients provided written informed consent, and research …

Background Little is known about generalisability of randomised controlled trials (RCTs) for
idiopathic pulmonary fibrosis (IPF). We evaluated eligibility criteria for phase III IPF RCTs to …

Rationale: Early access to subspecialty care is associated with improved outcomes for patients
with fibrotic interstitial lung disease (ILD). Access to ILD care may be limited for patients …